- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Hypoalbuminemia after surgery accelerated by presence of inflammation, finds study
Circulating albumin escapes from the plasma pool at a rate of 5% per hour, corresponding to an intravascular half-life (T1/2) of 7–10 hours. This leakage is accelerated after surgery and acute inflammation and is thought to be the cause of severe disease-related hypoalbuminemia.
These considerations cast doubt on the therapeutic usefulness of 20% albumin, which is often used to expand the plasma volume in major surgery and critical care, when the endothelium glycocalyx layer is frequently harmed. Volume expansion is strongly correlated with increased albumin levels in the circulation, and thus 'leaky capillaries' may impair administered albumin's intravascular persistence. Although inflammation and major surgery enhance albumin transcapillary leakage, it is unknown if exogenous albumin likewise departs more rapidly.Recently published study has given the insight useful in clinical scenarios.
In this study, Over a 30-minute period, 70 participants received an intravenous infusion of 3 mL/kg of 20% albumin: 15 healthy volunteers, 15 post-burn patients, 15 patients who had surgery with moderate bleeding, 10 patients who underwent surgery with substantial bleeding (mean, 1.1 L), and 15 postoperative patients. Blood haemoglobin and plasma albumin were tested 15 times during a 5-hour period. The rate at which albumin degrades in the plasma was quantified using population kinetics and expressed as the half-life (T1/2).
There were no variations in T1/2 between volunteers, post-burn patients, patients who had mild bleeding during surgery, and postoperative patients. The average T1/2 was 16.2 hours, which equates to 3.8 percent of the quantity injected every hour. Two groups exhibited plasma C-reactive protein concentrations of around 60 mg/L but had a similarly long T1/2 for albumin. By contrast, patients requiring significant hemorrhage-associated surgery had a shorter T1/2, equal to 15% of the albumin administered each hour. Additionally, our results demonstrate that the T1/2 values vary significantly depending on whether plasma volume changes and blood losses are included in the computations.
The intravascular T1/2 for excess albumin is significant for the therapeutic effectiveness of a 20% albumin solution, since one gramme of albumin binds 10–11 mL of plasma water. The 20% albumin preparation contains only 5 mL of fluid per gramme albumin, implying that an infusion recruits fluid from extravascular sources to the plasma. The maximal volume expansion of plasma is roughly double the volume injected.
When albumin was administered as a 20% solution to patients with inflammation secondary to post-burn damage, to patients having surgery without severe bleeding, or to patients evaluated one day after major surgery, no faster disappearance rate was seen. Albumin administered into these conditions persisted in the plasma for the same amount of time as seen in volunteers.
Clinical relevance –
Numerous clinical scenarios previously linked with endothelial injury did not exhibit a short T1/2 for exogenous albumin. Albumin was eliminated at rates that were not statistically different from those observed in healthy volunteers throughout moderately severe inflammatory conditions, during surgery without large bleeding, and during postoperative recovery after major surgery. In comparison, surgery involving significant bleeding showed a much shorter intravascular persistence.
Reference-
Zdolsek, M., Wuethrich, P.Y., Gunnström, M. et al. Plasma disappearance rate of albumin when infused as a 20% solution. Crit Care 26, 104 (2022). https://doi.org/10.1186/s13054-022-03979-1
MBBS, MD (Anaesthesiology), FNB (Cardiac Anaesthesiology)
Dr Monish Raut is a practicing Cardiac Anesthesiologist. He completed his MBBS at Government Medical College, Nagpur, and pursued his MD in Anesthesiology at BJ Medical College, Pune. Further specializing in Cardiac Anesthesiology, Dr Raut earned his FNB in Cardiac Anesthesiology from Sir Ganga Ram Hospital, Delhi.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751